158 related articles for article (PubMed ID: 20920372)
1. Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Mukherjee S; Roth MJ; Dawsey SM; Yan W; Rodriguez-Canales J; Erickson HS; Hu N; Goldstein AM; Taylor PR; Richardson AM; Tangrea MA; Chuaqui RF; Emmert-Buck MR
J Transl Med; 2010 Oct; 8():91. PubMed ID: 20920372
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Samantaray S; Sharma R; Chattopadhyaya TK; Gupta SD; Ralhan R
J Cancer Res Clin Oncol; 2004 Jan; 130(1):37-44. PubMed ID: 14569466
[TBL] [Abstract][Full Text] [Related]
3. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Li Y; Ma J; Guo Q; Duan F; Tang F; Zheng P; Zhao Z; Lu G
Dis Esophagus; 2009; 22(8):664-7. PubMed ID: 19191857
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
6. MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma.
Xue Z; Wu X; Chen X; Luo Q
Cancer Med; 2016 Sep; 5(9):2459-68. PubMed ID: 27292876
[TBL] [Abstract][Full Text] [Related]
7. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
Jiao XL; Chen D; Wang JG; Zhang KJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
[TBL] [Abstract][Full Text] [Related]
9. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Ohashi K; Nemoto T; Nakamura K; Nemori R
Cancer; 2000 May; 88(10):2201-9. PubMed ID: 10820340
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
12. DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.
Zou S; Shang ZF; Liu B; Zhang S; Wu J; Huang M; Ding WQ; Zhou J
Oncotarget; 2016 May; 7(22):32274-85. PubMed ID: 27057634
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Xie M; Sun Y; Li Y
Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial‑mesenchymal transition.
Xu G; Ou L; Liu Y; Wang X; Liu K; Li J; Li J; Wang S; Huang D; Zheng K; Wang S
Oncol Rep; 2020 Jul; 44(1):29-42. PubMed ID: 32627007
[TBL] [Abstract][Full Text] [Related]
16. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study.
Shima I; Sasaguri Y; Kusukawa J; Yamana H; Fujita H; Kakegawa T; Morimatsu M
Cancer; 1992 Dec; 70(12):2747-53. PubMed ID: 1451050
[TBL] [Abstract][Full Text] [Related]
17. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway.
Zou S; Yang J; Guo J; Su Y; He C; Wu J; Yu L; Ding WQ; Zhou J
Cancer Lett; 2018 Mar; 417():65-74. PubMed ID: 29306013
[TBL] [Abstract][Full Text] [Related]
18. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
19. Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.
Wang X; Li X; Li C; He C; Ren B; Deng Q; Gao W; Wang B
Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):520-7. PubMed ID: 27125974
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer.
Ahokas K; Karjalainen-Lindsberg ML; Sihvo E; Isaka K; Salo J; Saarialho-Kere U
Tumour Biol; 2006; 27(3):133-41. PubMed ID: 16641547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
